TY  - GEN
AU  - Posey,J A
AU  - Raspet,R
AU  - Verma,U
AU  - Deo,Y M
AU  - Keller,T
AU  - Marshall,J L
AU  - Hodgson,J
AU  - Mazumder,A
AU  - Hawkins,M J
TI  - A pilot trial of GM-CSF and MDX-H210 in patients with erbB-2-positive advanced malignancies
SN  - 1524-9557
PY  - 1999///0928
KW  - Adenocarcinoma
KW  - drug therapy
KW  - Adolescent
KW  - Adult
KW  - Aged
KW  - Antibodies, Bispecific
KW  - administration & dosage
KW  - Antibodies, Monoclonal
KW  - Antibodies, Monoclonal, Humanized
KW  - Antibody Formation
KW  - drug effects
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Cytokines
KW  - Disease-Free Survival
KW  - Dose-Response Relationship, Drug
KW  - Drug Administration Schedule
KW  - Female
KW  - Follow-Up Studies
KW  - Granulocyte-Macrophage Colony-Stimulating Factor
KW  - Humans
KW  - Injections, Subcutaneous
KW  - Leukocyte Count
KW  - Male
KW  - Middle Aged
KW  - Pilot Projects
KW  - Receptor, ErbB-2
KW  - blood
KW  - Severity of Illness Index
KW  - Survival Rate
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial; Journal Article
UR  - https://doi.org/10.1097/00002371-199907000-00011
ER  -